Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Hellings

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Allergo Journal International|February 21, 2017
Visual analogue scales (VAS): Measuring instruments for the documentation of symptoms and therapy monitoring in cases of allergic rhinitis in everyday health care: Position Paper of the German Society of Allergology (AeDA) and the German Society of Allergy and Clinical Immunology (DGAKI), ENT Section, in collaboration with the working group on Clinical Immunology, Allergology and Environmental Medicine of the German Society of Otorhinolaryngology, Head and Neck Surgery (DGHNOKHC)Ludger Klimek, Karl-Christian Bergmann, Tilo Biedermann, et al.
Expert Review of Clinical Immunology|September 2, 2015
Current controversies and challenges in allergic rhinitis managementDavid Price, Pete Smith, Peter Hellings, et al.
Expert Opinion on Pharmacotherapy|March 10, 2015
Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gapsJean Bousquet, Claus Bachert, Jonathan Bernstein, et al.
Tuberkuloz Ve Toraks|June 17, 2017
[ARIA 2016 executive summary: integrated care pathways for predictive medicine across the life cycle]Ayşe Arzu Yorgancıoğlu, Ömer Kalaycı, Cemal Cingi, et al.
The Journal of Allergy and Clinical Immunology|September 5, 2020
A 300 IR sublingual tablet is an effective, safe treatment for house dust mite-induced allergic rhinitis: An international, double-blind, placebo-controlled, randomized phase III clinical trialPascal Demoly, Jonathan Corren, Peter Creticos, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|December 29, 2023
Impact of Dupilumab on Sinonasal Symptoms and Outcomes in Severe Chronic Rhinosinusitis With Nasal PolypsClaire Hopkins, Joaquim Mullol, Asif H Khan, et al.
Respiratory Medicine|February 1, 2026
Corrigendum to "The EUFOREA pocket guide on paediatric asthma: A step forward in patient care" [Respir. Med. (2025) 108631]Milos Jesenak, Zuzana Diamant, Diego Conti, et al.
Respiratory Medicine|January 8, 2026
The EUFOREA pocket guide on paediatric asthma: A step forward in patient careMilos Jesenak, Zuzana Diamant, Diego Conti, et al.
The European Respiratory Journal|January 28, 2022
Allergen provocation tests in respiratory research: building on 50 years of experienceGail M Gauvreau, Beth E Davis, Guy Scadding, et al.
JAMA|February 3, 2016
Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis: A Randomized Clinical TrialClaus Bachert, Leda Mannent, Robert M Naclerio, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Allergo Journal International|February 21, 2017
Visual analogue scales (VAS): Measuring instruments for the documentation of symptoms and therapy monitoring in cases of allergic rhinitis in everyday health care: Position Paper of the German Society of Allergology (AeDA) and the German Society of Allergy and Clinical Immunology (DGAKI), ENT Section, in collaboration with the working group on Clinical Immunology, Allergology and Environmental Medicine of the German Society of Otorhinolaryngology, Head and Neck Surgery (DGHNOKHC)Ludger Klimek, Karl-Christian Bergmann, Tilo Biedermann, et al.
Expert Review of Clinical Immunology|September 2, 2015
Current controversies and challenges in allergic rhinitis managementDavid Price, Pete Smith, Peter Hellings, et al.
Expert Opinion on Pharmacotherapy|March 10, 2015
Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gapsJean Bousquet, Claus Bachert, Jonathan Bernstein, et al.
Tuberkuloz Ve Toraks|June 17, 2017
[ARIA 2016 executive summary: integrated care pathways for predictive medicine across the life cycle]Ayşe Arzu Yorgancıoğlu, Ömer Kalaycı, Cemal Cingi, et al.
The Journal of Allergy and Clinical Immunology|September 5, 2020
A 300 IR sublingual tablet is an effective, safe treatment for house dust mite-induced allergic rhinitis: An international, double-blind, placebo-controlled, randomized phase III clinical trialPascal Demoly, Jonathan Corren, Peter Creticos, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|December 29, 2023
Impact of Dupilumab on Sinonasal Symptoms and Outcomes in Severe Chronic Rhinosinusitis With Nasal PolypsClaire Hopkins, Joaquim Mullol, Asif H Khan, et al.
Respiratory Medicine|February 1, 2026
Corrigendum to "The EUFOREA pocket guide on paediatric asthma: A step forward in patient care" [Respir. Med. (2025) 108631]Milos Jesenak, Zuzana Diamant, Diego Conti, et al.
Respiratory Medicine|January 8, 2026
The EUFOREA pocket guide on paediatric asthma: A step forward in patient careMilos Jesenak, Zuzana Diamant, Diego Conti, et al.
The European Respiratory Journal|January 28, 2022
Allergen provocation tests in respiratory research: building on 50 years of experienceGail M Gauvreau, Beth E Davis, Guy Scadding, et al.
JAMA|February 3, 2016
Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis: A Randomized Clinical TrialClaus Bachert, Leda Mannent, Robert M Naclerio, et al.
Pageof 5